Supportive Oncodermatology in Pediatric Patients - 31/03/22
Doi : 10.1016/j.det.2021.12.007
Danny W. Linggonegoro, BS a, b, Hannah Song, MD a, b, Jennifer T. Huang, MD a, b, ⁎ 
a Boston Children's Hospital, Dermatology Program, 300 Longwood Avenue, Fegan 6, Boston, MA 02115, USA
b Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA
∗Corresponding author. 300 Longwood Avenue, Fegan 6, Boston, MA 02115.300 Longwood Avenue, Fegan 6BostonMA02115
Riassunto |
Cutaneous reactions to targeted therapies are varied and common. Pediatric dermatology literature is emerging on the specific types and prevalence of cutaneous reactions to targeted therapies that hone in on membrane-bound receptors, intracellular signaling targets, and antiangiogenesis agents, as well as targeted immunotherapies. Data regarding the timing, severity, and treatment algorithms are most plentiful for BRAF, MEK, and EGFR inhibitors.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Oncodermatology, Targeted therapy, Pediatric dermatology, Cutaneous reaction, Management
Mappa
© 2021
Elsevier Inc. Tutti i diritti riservati.
Vol 40 - N° 2
P. 203-214 - aprile 2022 Ritorno al numero
Articolo precedente
- Morbilliform Eruptions in the Hospitalized Child
- Jessica S. Haber, Sarah D. Cipriano, Vikash S. Oza
- Laser Surgery for Dermatologic Conditions in Pediatric Patients
- Deepti Gupta
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?